Безопасен ли benzothiazole при беременности?

Безопасные альтернативы benzothiazole при беременности | VeriMom

Related ingredients

Frequently asked questions

Безопасен ли benzothiazole при беременности?

No harmonised reproductive classification (no ECHA Annex VI H360/H361 entry) or CIR/SCCS cosmetic safety opinion was found for benzothiazole (CAS 95-16-9), but human epidemiology reports link prenatal urinary benzothiazole/benzothiazole‑derivatives to pregnancy outcomes (gestational diabetes, altered neonatal/child growth and thyroid hormones), supporting a cautious, low-level concern rather than confirmed teratogenicity. Sources: ECHA substance/C&L pages (no harmonised repro classification) and recent cohort studies reporting associations. ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.005.216?utm_source=openai))

Безопасен ли benzothiazole при грудном вскармливании?

No specific data were found showing benzothiazole is a proven developmental or lactation teratogen or that it is routinely classified for reproductive toxicity at EU harmonised level; however environmental/biomonitoring studies show maternal exposure and associations with endocrine/glucose outcomes, so a low-level (theoretical/epidemiology‑based) concern exists. Transfer into human milk was not identified in authoritative sources. Exposure from topical cosmetic use would be low but measurable if used. ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.005.216?utm_source=openai))

Безопасен ли benzothiazole для кожи малыша?

No infant‑specific studies demonstrating developmental toxicity via dermal cosmetic use were identified. Because benzothiazole is a small aromatic heterocycle that is detected in human biomonitoring (showing it can be absorbed) and infant skin has higher absorption per weight, exposure for 0–3 yr via topical application is increased vs adults (h and m unchanged in absence of infant‑specific hazard data). Epidemiology suggests systemic effects after environmental exposure but not a confirmed infant‑specific reproductive mechanism. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/40710023/?utm_source=openai))

Как VeriMom оценивает benzothiazole?

VeriMom оценивает benzothiazole в 67/100 (средний риск) на основе EU CosIng, классификаций ECHA и исследований PubMed.

Какие безопасные альтернативы benzothiazole при беременности?

См. наш список безопасных альтернатив benzothiazole с аналогичной функцией и классификацией без известных рисков.